World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Keywords:
Tags: Pharmaceutical, Britain,
Glaxo, like other pharmaceutical companies facing severe competition from generics, aggressively marketed the treatment for Restless Legs Syndrome (RLS) with its drug Requip. Glaxo made a strong marketing push for Requip with advertising in medical journals even before approval of Requip by the FDA, sending specialists to discuss treatment with general practitioners, and advertising strongly to consumers. Half of Requip's sales come from treatment of Parkinson's disease for which it was originally designed, the other half comes from RLS. Are their pressures to treat an expanding array of diseases merely to increase sales.
Changing marketing landscape for Drug Companies
10/02/2006
Controversial practices of some companies, Changes in the marketing strategies and practices of companies like Pfizer.
Grouped Articles
Glaxo Epilepsy Drug Is Linked to Defects Found in Newborns - WSJ.com
Wall Street Journal 10/02/2006
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Pfizer to Cut 20% Of U.S. Sales Force, Signaling End of Era - WSJ.com
Wall Street Journal 11/29/2006
AstraZeneca Vows to Work With FDA - WSJ.com
Wall Street Journal 11/28/2006
Cephalon Used Improper Tactics To Sell Drug, Probe Finds - WSJ.com
Wall Street Journal 11/21/2006
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
FDA and the drug safety, production and marketing practices of pharmaceutical companies.
07/01/2005
The increasing controversy surrounding the safety and marketing of many pharmaceutical products and the role of the FDA in ensuring safe use and avoiding risks to users.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Plan Would Aid Drug Makers in Liability Suits
Wall Street Journal 01/14/2006
FDA Moves Toward Harder Line on Suicide Risks
Wall Street Journal 07/01/2005
Baxter Infusion Pumps Are Target of FDA Probe
Wall Street Journal 07/22/2005
Financial Ties to Industry Cloud Major Depression Study
Wall Street Journal 07/11/2006
Avandia Concerns Reopen a Wider Debate
Wall Street Journal 05/23/2007
Safety and marketing issues raised about drugs generating large sales for pharmaceutical companies.
10/25/2006
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Medical Journal Spikes Article On Industry Ties Of Kidney Group - WSJ.com
Wall Street Journal 12/26/2006
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Suit Details How J&J Pushed Sales of Procrit
Wall Street Journal 05/10/2007
BusinessWeek 05/21/2007
Sequel for Vioxx Critic: Attack on Diabetes Pill
Wall Street Journal 05/22/2007
European pharmaceutical companies and marketing practices.
10/25/2006
Grouped Articles
Big Pharma Faces Grim Prognosis
Wall Street Journal 12/06/2007
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
Digital Tools and marketing in the Pharmaceutical Industry
10/25/2006
How drug makers are using websites, the internet and digital tools to reshape marketing and reduce the number of salespeople.
Grouped Articles
Drug Makers Replace Reps With Digital Tools
Wall Street Journal 05/10/2011
Drug Reps Soften Their Sales Pitches
Wall Street Journal 01/10/2012
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
Large legal settlements in the pharmaceutical industry.
10/25/2006
The settlements also involve drug pricing and marketing.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
In Guilty Plea, OxyContin Maker to Pay $600 Million
New York Times 05/10/2007
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Drug Approval Is Not a Shield From Lawsuits, Justices Rule
New York Times 03/05/2009
Slimming down marketing and sales at American and European pharmaceutical companies.
10/25/2006
American and European drug companies are slimming down marketing and sales as the old marketing practices are not working, and new strategies are taking their place.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Wall Street Journal 01/16/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Wall Street Journal 10/21/2008
Aggressive television advertising by Pfizer and Glaxo Smithkline
10/25/2006
Linked Articles
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Glaxo to Pare Ads on U.S. Television
Wall Street Journal 01/09/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us